Kentucky Retirement Systems Insurance Trust Fund Purchases 1,956 Shares of Humana Inc. (NYSE:HUM)

Kentucky Retirement Systems Insurance Trust Fund boosted its position in Humana Inc. (NYSE:HUM) by 54.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,521 shares of the insurance provider’s stock after purchasing an additional 1,956 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Humana were worth $1,401,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Pinnacle Wealth Management Advisory Group LLC raised its holdings in Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock worth $272,000 after purchasing an additional 37 shares in the last quarter. Atlas Brown Inc. grew its stake in shares of Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock worth $1,611,000 after acquiring an additional 38 shares during the last quarter. Moors & Cabot Inc. grew its stake in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after acquiring an additional 40 shares during the last quarter. Mather Group LLC. grew its stake in shares of Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock worth $60,000 after acquiring an additional 41 shares during the last quarter. Finally, OLD National Bancorp IN grew its stake in shares of Humana by 1.8% in the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock worth $828,000 after acquiring an additional 45 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Up 1.3 %

HUM stock opened at $257.24 on Wednesday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business’s 50-day moving average is $270.05 and its two-hundred day moving average is $291.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $30.97 billion, a price-to-earnings ratio of 22.78, a P/E/G ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, analysts forecast that Humana Inc. will post 16.11 earnings per share for the current year.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Morgan Stanley cut their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Piper Sandler increased their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. TD Cowen increased their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Nineteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $285.68.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.